{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:42:23Z","timestamp":1768513343424,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023233","name":"National Institute for Health and Care Research Applied Research Collaboration Oxford and Thames Valley","doi-asserted-by":"publisher","award":["NF-SI-0616-10103"],"award-info":[{"award-number":["NF-SI-0616-10103"]}],"id":[{"id":"10.13039\/501100023233","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128067","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:09:41Z","timestamp":1765966181000},"page":"128067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Primary healthcare costs associated with the AstraZeneca COVID-19 vaccine in England"],"prefix":"10.1016","volume":"72","author":[{"given":"Joan E.","family":"Madia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catia","family":"Nicodemo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Petrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"de Lusignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128067_bb0005","unstructured":"World Health Organization. Coronavirus disease (COVID-19) pandemic [Internet]. 2024 [cited 2024 May]. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"key":"10.1016\/j.vaccine.2025.128067_bb0010","doi-asserted-by":"crossref","first-page":"n2082","DOI":"10.1136\/bmj.n2082","article-title":"Covid-19 booster vaccines: what we know and who\u2019s doing what","volume":"374","author":"Mahase","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2025.128067_bb0015","unstructured":"UK Health Security Agency. Coronavirus (COVID-19) in the UK [Internet]. 2024 [cited 2024 Jun 24]. Available from: https:\/\/coronavirus.data.gov.uk\/."},{"key":"10.1016\/j.vaccine.2025.128067_bb0020","unstructured":"National Health Service. A&E attendances and emergency admissions 2023-24 [Internet]. 2024 [cited 2025 Aug 15]. Available from: https:\/\/www.england.nhs.uk\/statistics\/statistical-work-areas\/covid-19-hospital-activity\/."},{"key":"10.1016\/j.vaccine.2025.128067_bb0025","unstructured":"Office for National Statistics. Excess deaths in England during the COVID-19 pandemic: January 2021 report [Internet]. 2021 [cited 2025 Aug 15]. Available from: ONS website."},{"key":"10.1016\/j.vaccine.2025.128067_bb0030","unstructured":"National Health Service England. COVID-19 hospital activity: January 2021 [Internet]. 2021 [cited 2025 Aug 15]. Available from: https:\/\/www.england.nhs.uk\/statistics\/statistical-work-areas\/covid-19-hospital-activity\/."},{"issue":"4","key":"10.1016\/j.vaccine.2025.128067_bb0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S2213-2600(20)30579-8","article-title":"Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data","volume":"9","author":"Navaratnam","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128067_bb0040","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1473-3099(21)00079-7","volume":"21","author":"Sandmann","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128067_bb0045","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/13696998.2021.1965732","article-title":"Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysis","volume":"24","author":"Padula","year":"2021","journal-title":"J Med Econ"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128067_bb0050","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/infdis\/jiac243","article-title":"Cost-effectiveness of coronavirus disease 2019 vaccination in low- and middle-income countries","volume":"226","author":"Siedner","year":"2022","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128067_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2021.02.054","article-title":"A cost-effectiveness evaluation of hospitalizations, fatalities, and economic outcomes associated with universal versus anaphylaxis risk-stratified COVID-19 vaccination strategies","volume":"9","author":"Shaker","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128067_bb0060","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s40261-021-01085-8","article-title":"The cost-effectiveness of a COVID-19 vaccine in a Danish context","volume":"41","author":"Debrabant","year":"2021","journal-title":"Clin Drug Investig"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128067_bb0065","doi-asserted-by":"crossref","DOI":"10.2196\/19773","article-title":"The Oxford Royal College of general practitioners clinical informatics digital hub: protocol to develop extended COVID-19 surveillance and trial platforms","volume":"6","author":"de Lusignan","year":"2020","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.vaccine.2025.128067_bb0070","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1016\/S2589-7500(22)00123-6","article-title":"Remote COVID-19 assessment in primary care (RECAP) risk prediction tool: derivation and real-world validation studies","volume":"4","author":"Espinosa-Gonzalez","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128067_bb0075","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jinf.2022.04.016","article-title":"Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network","volume":"84","author":"Whitaker","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2025.128067_bb0080","unstructured":"National Health Service. Prescription cost analysis \u2013 England 2020\/2021 [Internet]. 2021 [cited 2025 Aug 15]. Available from:https:\/\/www.nhsbsa.nhs.uk\/statistical-collections\/prescription-cost-prescription-cost-analysisngland202122#:\u223c:text=Key%20findings,in%20England%20was%201.14%20billion."},{"key":"10.1016\/j.vaccine.2025.128067_bb0085","unstructured":"Personal Social Services Research Unit. Unit Costs of Health and Social Care 2021 [Internet]. 2021 [cited 2025 Aug 15]. Available from: https:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/unit-costs-of-health-and-social-care-2021\/."},{"key":"10.1016\/j.vaccine.2025.128067_bb0090","unstructured":"UK Parliament, Public Accounts Committee. COVID-19: Planning for the Vaccine (Part 1) [Internet]. 2021 [cited 2024 Nov]. Available from: https:\/\/committees.parliament.uk\/work\/904\/covid19-planning-for-the-vaccine-part-1."},{"key":"10.1016\/j.vaccine.2025.128067_bb0095","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128067_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106129","article-title":"AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: the RAVEN cohort study","volume":"88","author":"Meeraus","year":"2024","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128067_bb0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1017\/pan.2018.29","article-title":"A theory of statistical inference for matching methods in causal research","volume":"27","author":"Iacus","year":"2019","journal-title":"Polit Anal"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128067_bb0110","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1503\/cmaj.190757","article-title":"Development and validation of the Cambridge multimorbidity score","volume":"192","author":"Payne","year":"2020","journal-title":"CMAJ"},{"issue":"731","key":"10.1016\/j.vaccine.2025.128067_bb0115","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.3399\/BJGP.2022.0235","article-title":"Development of a modified Cambridge multimorbidity score for use with SNOMED CT: an observational English primary care sentinel network study","volume":"73","author":"Tsang","year":"2023","journal-title":"Br J Gen Pract"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128067_bb0120","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1080\/13696998.2024.2413288","article-title":"The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA autumn 2024 vaccines in the United Kingdom","volume":"27","author":"Kohli","year":"2024","journal-title":"J Med Econ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:49:52Z","timestamp":1768459792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25013659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":24,"alternative-id":["S0264410X25013659"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary healthcare costs associated with the AstraZeneca COVID-19 vaccine in England","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128067"}}